Overexpression of the PTPN22 Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4(+) T Cell Activation. Perry DJ, Peters LD, Lakshmi PS, Zhang L, et al. J Immunol 2021;207:849-859.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Perry DJ, Peters LD, Lakshmi PS, Zhang L, et al. Overexpression of the PTPN22 Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4(+) T Cell Activation. J Immunol 2021;207:849-859.
PMID: 34301848